June 30, 2017 M&A, Partnerships

Precipio Diagnostics and Transgenomic Complete Merger

Company Renamed Precipio, Inc.–To Commence Trading On NASDAQ Under The New Ticker “PRPO” NEW HAVEN, Conn. and OMAHA, Neb., (June 30, 2017) – Precipio Diagnostics, LLC and Transgenomic Inc. (OTCQB: TBIOD) today announced the closing of their previously announced merger. In connection with the transaction, Transgenomic has changed its name to Precipio, Inc. Precipio’s common stock... Read more

April 17, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Life Science Tools M&A, Partnerships PR/Corporate

Transgenomic Closes Bridge Financing

Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more